Henan Lingrui Pharmaceutical Co., Ltd — Investor Relations & Filings
About Henan Lingrui Pharmaceutical Co., Ltd
Henan Lingrui Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of pharmaceutical products, with a primary focus on transdermal drug delivery systems. The company is a prominent producer of rubber plasters and external application medicines, notably its range of pain relief patches used for musculoskeletal and joint conditions. Its product portfolio extends to oral formulations, including capsules and tablets targeting cardiovascular health and inflammatory ailments. By integrating traditional medicinal principles with modern delivery technologies, the company provides a diverse array of therapeutic solutions. Its operations encompass the entire value chain from raw material processing to large-scale production and distribution, maintaining a significant presence in clinical and consumer healthcare markets through its specialized focus on external analgesic treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 羚锐制药关于会计师事务所2025年度履职情况评估报告 | 2026-04-27 | Chinese | |
| 董事会审计委员会2025年度履职情况报告 | 2026-04-27 | Chinese | |
| 羚锐制药审计报告 | 2026-04-27 | Chinese | |
| 独立董事候选人声明与承诺(王钊) | 2026-04-27 | Chinese | |
| 羚锐制药2025年度利润分配方案公告 | 2026-04-27 | Chinese | |
| 羚锐制药关于大股东部分股份质押的公告 | 2026-03-24 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 40670579 | 羚锐制药关于会计师事务所2025年度履职情况评估报告 | 2026-04-27 | Chinese | ||
| 40670576 | 董事会审计委员会2025年度履职情况报告 | 2026-04-27 | Chinese | ||
| 40670563 | 羚锐制药审计报告 | 2026-04-27 | Chinese | ||
| 40670561 | 独立董事候选人声明与承诺(王钊) | 2026-04-27 | Chinese | ||
| 40670559 | 羚锐制药2025年度利润分配方案公告 | 2026-04-27 | Chinese | ||
| 40670558 | 羚锐制药关于大股东部分股份质押的公告 | 2026-03-24 | Chinese | ||
| 40670554 | 羚锐制药关于获得药品注册证书的公告 | 2026-03-23 | Chinese | ||
| 40670550 | 羚锐制药关于大股东部分股份质押的公告 | 2026-03-19 | Chinese | ||
| 40670541 | 羚锐制药董事减持股份结果公告 | 2026-01-14 | Chinese | ||
| 40670537 | 羚锐制药关于大股东部分股份质押的公告 | 2026-01-14 | Chinese | ||
|
2025
5 filings
| |||||
| 40670530 | 羚锐制药关于“提质增效重回报”行动方案的公告 | 2025-12-31 | Chinese | ||
| 40670524 | 羚锐制药关于高级管理人员辞职的公告 | 2025-12-30 | Chinese | ||
| 40670516 | 羚锐制药关于大股东部分股份解除质押的公告 | 2025-11-21 | Chinese | ||
| 40670509 | 河南羚锐制药股份有限公司董事会议事规则 | 2025-11-18 | Chinese | ||
| 40670502 | 羚锐制药2025年第一次临时股东大会决议公告 | 2025-11-18 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Henan Lingrui Pharmaceutical Co., Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56622/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56622 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56622 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56622 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56622}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Henan Lingrui Pharmaceutical Co., Ltd (id: 56622)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.